Advanced Therapies Congress London 2026

NorthX Biologics is excited to join the Advanced Therapies Congress 2026, taking place 17–18 March at ExCeL London.
As Europe’s leading event for cell and gene therapies, the congress brings together the most influential voices shaping the future of ATMPs. Our CEO, Janet Hoogstraate, will be speaking, sharing insights on advanced biomanufacturing and the innovation driving our sector forward.

We look forward to meeting partners, collaborators, and industry leaders in London.

When: March 17-18, 2026
Where: London, UK

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on LinkedIn